Clera home
·Dashboard

Jobs at Humacyte (Now Hiring) — 4 open

Humacyte logoHumacyte

CQV Engineer II/III

Durham, North Carolina, United States · On-site

Mid level$956M raised

DEPARTMENT: Quality LOCATION: Durham, NC, Onsite/Not Remote COMPANY: Humacyte Inc (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced …

Skills: Commissioning, Qualification, Validation, cGMP, GAMP

Humacyte logoHumacyte

Senior Associate, Regulatory CMC

Durham, North Carolina, United States · Remote OK

Senior$956M raised

DEPARTMENT: Regulatory Affairs LOCATION: Durham, NC, Fully Remote COMPANY: Humacyte Inc (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, adv…

Skills: Regulatory CMC, Biological Products, Cell Therapy, Regulatory Submissions, CMC Strategy

Humacyte logoHumacyte

Head of Pharmacovigilance

United States · Hybrid

Senior+$956M raised

DEPARTMENT: CMO Dept. LOCATION: Durham, NC, Partially Remote COMPANY: Humacyte Inc (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced…

Skills: Pharmacovigilance, Safety Oversight, Signal Detection, Risk Management Plans, GVP Compliance

Humacyte logoHumacyte

Executive Director, Clinical Development & Medical Affairs

Durham, North Carolina, United States · Hybrid

Senior+$956M raised

DEPARTMENT: Clinical Operations LOCATION: Durham, NC, Partially Remote COMPANY: Humacyte Inc (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues…

Skills: Clinical Development Strategy, Medical Affairs, Clinical Trial Management, Regulatory Dossiers, People Leadership

Humacyte logo

CQV Engineer II/III

Humacyte

Durham, North Carolina, United States • On-site

Apply
Mid level

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

  • Full-time
  • bachelor degree
  • Stock Options, 401k Plan With 4% Match, Medical Plan, Vision Plan, Dental Plan, Company Paid Long Term Disability
  • Posted 4d ago
  • ~40 hrs/week

Responsibilities

Responsible for writing, executing, and summarizing commissioning, qualification, and validation protocols for computerized systems, laboratory instruments, and manufacturing equipment. The role involves developing validation specifications, master plans, and performing periodic reviews in accordance with cGMP and SOPs.

Requirements

Requires a Bachelor's degree in Engineering, mathematics, or a scientific field with 3-5 years of direct CQV experience. Preference is given to candidates with pharmaceutical or biotech experience and familiarity with Kaye AVS or Veriteq systems.

Full job description

DEPARTMENT: Quality

LOCATION: Durham, NC, Onsite/Not Remote

COMPANY: Humacyte Inc (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ systems designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Humacyte’s initial opportunity, a portfolio of Acellular Tissue Engineered Vessel (ATEVs), is currently approved for use in vascular trauma repair and is in late-stage clinical trials targeting multiple other applications including AV access for hemodialysis and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte’s 6mm ATEV for AV access in hemodialysis was the first product candidate to receive the FDA’s Regenerative Medicine Advanced Therapy (RMAT) designation and has also received FDA Fast Track designation. Humacyte’s 6mm ATEV for urgent arterial repair following extremity vascular trauma also received the RMAT designation. For more information, visit www.Humacyte.com.

JOB SUMMARY:

The CQV Engineer II / III will be responsible for writing, execution, and summary of commissioning, qualification, and validation protocols related to local and enterprise based computerized systems, laboratory instruments, manufacturing equipment, and facility and utility-based systems. They will support the development of validation specifications, assessments and master plans. They will prepare and complete periodic reviews and requalifications in a timely manner. All work to be conducted according to governing SOPs and cGMPs (current Good Manufacturing Practices).

 

ESSENTIAL FUNCTIONS:

  • Support activities related to commissioning, qualification, and validation of facility, utilities, laboratory instruments, manufacturing equipment, and computerized systems
  • Lead the creation and revision of validation assessments, including GAMP and electronic records and signatures assessments.
  • Familiar with Kaye AVS and Veriteq temperature mapping systems
  • Familiar with computerized maintenance management systems, (CMMS) like BMRAM. 
  • Take part in the development and revision of validation specifications including URS, FRS, CS, and DS, as well as Trace Matrices.
  • Assist in the development of project or system specific Validation Plans.
  • Write, execute, and summarize commissioning, qualification, and validation protocols.
  • Identify and support the resolution of protocol deviations noted during protocol execution and review.
  • Assist in root cause analysis related to QA Deviations / Non-conformance events.
  • Adheres to periodic review and requalification schedule for systems per procedure and established plans.
  • Revise internal and external departmental procedures based on previously obtained CQV data.
  • Present findings and results from completed CQV deliverables in internal and external audits specific to work which was performed firsthand.
  • Represent the CQV team in internal meetings.
  • Other Duties as assigned.

EXPERIENCE & QUALIFICATIONS:

  • 3 - 5 years of direct commissioning, qualification, validation, and/or validation experience, required. 
  • 3 years of pharmaceutical / biotech experience preferred.
  • Bachelor’s degree, required, preferably in a technical program such as Engineering, mathematics, or a scientific based field.
  • Specialized or strong experiences in one of the following areas:
    • Site or enterprise based computerized systems
    • Laboratory instruments
    • Manufacturing equipment
    • Automation systems
    • Facility and utilities
    • Periodic Reviews
    • Temperature mapping equipment such as Kaye and Veriteq
  • Strong working knowledge of good documentation practices and FDA, EudraLex, and other regulatory agency regulations and guidance, preferred.
  • Ability to lift up to 20 pounds, required.
  • Willingness to regularly, predictably, and reliably perform required functions at work, including occasional work outside typical office hours and weekends.
  • Excellent communication and interpersonal skills.
  • Possess a positive roll-up-the-sleeves attitude and optimistic outlook.
  • Strong ability to work in a fast-paced team environment with fluctuating priorities and demonstrated ability to collaborate within cross functional teams.
  • Excellent organizational and time management skills with ability to set own priorities in a timely manner.
  • High degree of flexibility and adaptability. 
  • Self-motivated and organized critical thinker with solid interpersonal and business communication skills.
  • Represents the organization in a positive and highly professional manner.

COMPENSATION & BENEFITS HIGHLIGHTS:

  • Stock Options
  • 401k Plan with 4% Match and no Vesting Schedule
  • Medical, Vision and Dental Plans
  • Company Paid Long Term/Short Term Disability
  • Company Paid Life Insurance
  • 23 Days Paid Time Off (PTO)
  • 10 Company Designated Holidays + 2 Floating Holidays
  • Paid Parental Leave Policies

Please note, Humacyte does not provide U.S. employment sponsorship and does not accept unsolicited resumes from 3rd party firms and/or agency recruiters.

The statements in this position profile are intended to describe the general nature and level of work being performed by people assigned to this classification. They are not intended to be construed as an exhaustive list of responsibilities, duties, and skills required of personnel so classified. The manager may assign additional responsibilities and assignments from time to time. Humacyte is an equal opportunity employer and is committed to providing equal employment opportunities without regard to age, race, religion, sex, sexual orientation, gender identity, national origin, Veterans status, disability and/or other protected class characteristics. Additionally, Humacyte is committed to achieving its business objectives in compliance with all federal, state and local law.

Related keywords

CQVcGMPGAMPKaye AVSVeriteqBMRAMURSFRSCSDSTrace MatricesFDAEudraLexAcellular TissueBiotechnologyValidation Plan

About Humacyte

LinkedInVisit site

Our vision is to be the global leader in engineering regenerative medicine products to save and improve patient lives.

Industry
Biotechnology Research
Company size
201-500 employees
Founded
2004
Headquarters
Durham, NC
LinkedIn followers
16,212
Total funding
$956M

Humacyte, Inc. (Nasdaq: HUMA) is proud to announce that in Dec 2024, FDA granted full approval for our Acellular Tissue Engineered Vessel (ATEV), a first-in-class, universally implantable, bioengineered human vessel for extremity arterial trauma. This approval is a significant milestone in regenerative medicine, offering a new treatment option for patients with severe arterial injuries.See the Prescribing Information, including Boxed Warning: https://bit.ly/4dl5tuL This is the first approval in our bioengineered ATEV Platform where we are continuing to investigate use of our lab-grown tissues and organs to improve the lives of patients and transform the practice of medicine. We develop and manufacture acellular tissues that are meant to be universally implantable and remodel with the patient's own cells over time. The goal is to grow spare parts for people. Humacyte’s ATEV is in clinical trials for arteriovenous access for hemodialysis, and peripheral arterial disease. Investigational preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte’s ATEV for performing hemodialysis in AV Access was the first indication to receive the FDA’s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the ATEV technology received priority designation for the treatment of extremity arterial repair by the U.S. Secretary of Defense prior to its FDA approval in Dec 2024 for that purpose. For more information, visit https://Humacyte.com.

Offices: 2525 E NC Highway 54, 2525 E Hwy 54, Durham, NC 27713, US

Regenerative Medicinebiotechnologyand bioengineeringMedical DeviceBiotechnologyMedical
View all jobs at Humacyte

About Humacyte

LinkedInVisit site

Our vision is to be the global leader in engineering regenerative medicine products to save and improve patient lives.

Industry
Biotechnology Research
Company size
201-500 employees
Founded
2004
Headquarters
Durham, NC
LinkedIn followers
16,212
Total funding
$956M

Humacyte, Inc. (Nasdaq: HUMA) is proud to announce that in Dec 2024, FDA granted full approval for our Acellular Tissue Engineered Vessel (ATEV), a first-in-class, universally implantable, bioengineered human vessel for extremity arterial trauma. This approval is a significant milestone in regenerative medicine, offering a new treatment option for patients with severe arterial injuries.See the Prescribing Information, including Boxed Warning: https://bit.ly/4dl5tuL This is the first approval in our bioengineered ATEV Platform where we are continuing to investigate use of our lab-grown tissues and organs to improve the lives of patients and transform the practice of medicine. We develop and manufacture acellular tissues that are meant to be universally implantable and remodel with the patient's own cells over time. The goal is to grow spare parts for people. Humacyte’s ATEV is in clinical trials for arteriovenous access for hemodialysis, and peripheral arterial disease. Investigational preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte’s ATEV for performing hemodialysis in AV Access was the first indication to receive the FDA’s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the ATEV technology received priority designation for the treatment of extremity arterial repair by the U.S. Secretary of Defense prior to its FDA approval in Dec 2024 for that purpose. For more information, visit https://Humacyte.com.

Offices: 2525 E NC Highway 54, 2525 E Hwy 54, Durham, NC 27713, US

Regenerative Medicinebiotechnologyand bioengineeringMedical DeviceBiotechnologyMedical
View all jobs at Humacyte

Similar companies hiring

Thermo Fisher Scientific (2270)Roche (1113)CSL (956)Amgen (851)ICON plc (715)Syneos Health (390)Mineralys Therapeutics, Inc. (315)Fortrea (250)Agilent Technologies (241)Gilead Sciences (198)BeiGene (166)Genentech (164)
Clera home

Your AI-talent agent. Connecting talents with dream jobs.

Earn $5,000

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

© 2026 Clera Labs, Inc.

PrivacyTermsBug Bounty